ZINNAT 125 mg, film-coated tablet 8 tablets
Active ingredients: Cefuroxime, Cefuroxime axetil
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet8 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ZINNAT 125 mg, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé
- Route of administration
- orale
- Presentation description
- plaquette(s) thermoformée(s) aluminium de 8 comprimé(s)
- Marketing authorisation holder
- SANDOZ
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 24 Aug 2026
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
63424838CIP73312154CIP133400933121549Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CÉFUROXIME AXÉTILcomprimé | — | SA |
| CÉFUROXIMEcomprimé | 125 mg · un comprimé | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The published catalog does not list other packages of similar medicines.